Basilea Pharmaceutica AG (BSLN.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: 38.52%; 2025 (actual)
ROA: 14.91%; 2025 (actual)
Gross Margin: 83.08%; 2025 (actual)
Net Margin: 17.32%; 2025 (actual)
Total Assets: CHF 282.00M; 2025 (actual)
Net Income: CHF 40.24M; 2025 (actual)
Valuation: CHF 677.83M; 2025 (actual)
Stock Price: CHF 54.70; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	38.52%	27.5%	25.03%	22.64%	20.42%	18.04%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	14.91%	13.44%	13.61%	13.26%	12.72%	11.85%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	83.08%	83.08%	83.08%	83.08%

Amounts in CHF (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Basilea Pharmaceutica AG? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 282.00M	CHF 325.01M	CHF 384.58M	CHF 450.88M	CHF 522.99M	CHF 595.89M
Sector average	CHF 6,583.66M	CHF 7,029.78M	CHF 7,875.11M	CHF 8,842.33M	CHF 9,880.55M	CHF 10,888.36M

Net Income	CHF 40.24M	CHF 40.80M	CHF 48.27M	CHF 55.40M	CHF 61.95M	CHF 66.30M
Sector average	CHF 509.04M	CHF 497.74M	CHF 567.21M	CHF 655.95M	CHF 738.04M	CHF 795.14M

Valuation	CHF 677.83M	CHF 691.04M	CHF 703.96M	CHF 716.62M	CHF 729.10M	CHF 741.64M
Sector average	CHF 12,182.57M	CHF 13,169.96M	CHF 13,319.59M	CHF 13,502.66M	CHF 13,728.88M	CHF 13,908.08M

Stock Price	CHF 54.70	CHF 55.77	CHF 56.81	CHF 57.83	CHF 58.84	CHF 59.85
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32